It indicates prior or acute infection with, or immunization to, Hepatitis A virus. Immunoglobulin M (IgM) antibodies to Hepatitis A suggest a current, acute or recent Hepatitis A infection.
The Hepatitis B vaccine is recommended for those who have not been previously vaccinated. This test looks for IgM antibody to hepatitis B core antigen and is a reliable marker for acute hepatitis B infection.
Hepatitis B Virus (HBV) is one of the several viruses that cause hepatitis. HBV PCR test measures the amount of HBV genetic material in the blood.
Also Known As: HBV PCR
Surface antigen usually appears in the serum following exposure to Hepatitis B virus and peaks shortly after onset of symptoms. It typically disappears within 1 to 3 months. Persistence of Hepatitis B surface antigen for greater than 6 months is a prognostic indicator of chronic Hepatitis B infection.
Also Known As: Hepatitis B Immunity Test, Hep B Titer
Surface antigen usually appears in the serum following exposure to Hepatitis B virus and peaks shortly after onset of symptoms. It typically disappears within 1 to 3 months. Persistence of Hepatitis B surface antigen for greater than 6 months is a prognostic indicator of chronic Hepatitis B infection.
Surface antigen usually appears in the serum following exposure to Hepatitis B virus and peaks shortly after onset of symptoms. It typically disappears within 1 to 3 months. Persistence of Hepatitis B surface antigen for greater than 6 months is a prognostic indicator of chronic Hepatitis B infection.
The clinical symptoms of an HCV infection are variable. Infection with HCV results in a chronic infection in 50 to 80% of cases. The window between HCV acquisition and sero-reactivity is highly variable; up to six months.
The clinical symptoms of an HCV infection are variable. Infection with HCV results in a chronic infection in 50 to 80% of cases. The "window" between HCV acquisition and sero-reactivity is highly variable; up to six months.
The clinical symptoms of an HCV infection are variable. Infection with HCV results in a chronic infection in 50 to 80% of cases. The "window" between HCV acquisition and sero-reactivity is highly variable; up to six months.